세계의 방사선 독성 치료 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 제품 유형별, 적응증별, 방사선 유형별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Radiation Toxicity Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Indication, By Radiation Type, By End-user By Region & Competition, 2020-2030F

US $ 4,500 ￦ 6,233,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,619,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,082,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

방사선 독성 치료 세계 시장 규모는 2024년 24억 8,000만 달러로 평가되었습니다. 2030년까지 예측 기간 동안 연평균 5.40%의 꾸준한 성장이 예상됩니다.

방사선 독성 치료 세계 시장은 암 발병률 증가와 암 치료에서 방사선 치료의 사용 확대로 인해 최근 몇 년동안 괄목할 만한 성장과 진화를 거듭하고 있습니다. 방사선 치료는 종양학에서 중요한 수단이지만, 방사선 독성을 유발할 수 있어 전문적인 치료 및 관리 전략이 필요한 경우가 많습니다. 이 시장에는 방사선 치료의 부작용을 완화하고 치료하기 위한 다양한 제품 및 서비스가 포함되어 있으며, 방사선 치료는 현대 암 치료에서 필수적인 요소로 자리 잡고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	24억 8,000만 달러
시장 규모 : 2030년	34억 1,000만 달러
CAGR : 2025-2030년	5.40%
급성장 부문	만성 방사선 증후군
최대 시장	북미

이 시장의 성장 촉진요인은 전 세계 암 발병률 증가입니다. 전 세계적으로 암 발병률이 지속적으로 증가함에 따라 방사선 치료를 받는 환자 수도 크게 증가하고 있습니다. 그러나 방사선 치료에 부작용이 없는 것은 아니며, 피부반응, 위장장애, 장기장애 등의 방사선 독성이 일반적인 우려사항으로 대두되고 있습니다. 이 때문에 의약품, 의료기기, 지지요법 서비스 등 방사선 독성 치료 옵션에 대한 수요가 증가하고 있습니다. 의약품은 방사선 독성 치료 시장에서 중요한 부분을 차지하고 있으며, 방사선 독성 증상을 관리하고 완화하기 위해 개발된 의약품과 약물이 있습니다. 이러한 의약품에는 항염증제, 성장인자, 방사선 보호제 등이 포함됩니다. 또한, 표적치료제와 면역조절제의 발전은 방사선 치료의 효과를 향상시키고 관련 독성을 감소시킬 수 있을 것으로 기대됩니다.

주요 시장 성장 촉진요인

암 발병률 증가

주요 시장 이슈

제한된 인식과 교육

주요 시장 동향

방사선 보호제 및 지지요법

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 방사선 독성 치료 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 제품별(콜로니 자극 인자, 요오드화 칼륨, 프로이센 블루 디에틸렌트리아민 펜타아세트산, 기타)
  • 적응증별(급성 방사선 증후군, 만성 방사선 증후군)
  • 방사선 유형별(전리 방사선, 비전리 방사선)
  • 최종사용자별(병원 및 진료소, 외래 진료 센터, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 방사선 독성 치료 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 방사선 독성 치료 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 방사선 독성 치료 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 방사선 독성 치료 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 방사선 독성 치료 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 인수합병(M&A)

제13장 세계의 방사선 독성 치료 시장 : SWOT 분석

제14장 경쟁 구도

• Amgen Inc.
• Jubilant Pharma Limited
• Tanner Pharma Group
• Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
• Recipharm AB
• Mission Pharmacal Company
• Partner Therapeutics, Inc.
• Novartis AG
• Viatris Inc.
• Coherus Biosciences Inc.

제15장 전략적 제안

제16장 리서치사에 대해 & 면책사항

LSH

영문 목차

영문목차

Global Radiation Toxicity Treatment Market was valued at USD 2.48 Billion in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 5.40% through 2030. The Global Radiation Toxicity Treatment Market has witnessed significant growth and evolution in recent years, driven by the increasing incidence of cancer and the expanding use of radiation therapy in cancer treatment. Radiation therapy, while a crucial tool in oncology, can lead to radiation toxicity, which often necessitates specialized treatments and management strategies. This market encompasses a wide range of products and services aimed at mitigating and treating the adverse effects of radiation therapy, making it an essential component of modern cancer care.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.48 Billion
Market Size 2030	USD 3.41 Billion
CAGR 2025-2030	5.40%
Fastest Growing Segment	Chronic Radiation Syndrome
Largest Market	North America

The primary drivers of this market's growth is the rising global cancer burden. As cancer incidence continues to rise worldwide, the number of patients undergoing radiation therapy has increased substantially. However, radiation therapy is not without its side effects, and radiation toxicity, including skin reactions, gastrointestinal issues, and organ damage, is a common concern. This has spurred the demand for radiation toxicity treatment options, including pharmaceuticals, medical devices, and supportive care services. Pharmaceuticals form a crucial segment of the radiation toxicity treatment market, with drugs and medications developed to manage and alleviate the symptoms of radiation toxicity. These pharmaceuticals include anti-inflammatory agents, growth factors, and radioprotective drugs. Additionally, advancements in targeted therapies and immunomodulators hold promise for improving the effectiveness of radiation therapy while reducing associated toxicities.

Key Market Drivers

Increasing Cancer Prevalence

The escalating global incidence of cancer significantly propels the growth of the Radiation Toxicity Treatment Market. This surge in cancer cases leads to increased utilization of radiation therapy, consequently amplifying the demand for treatments addressing radiation-induced toxicities. Recent studies indicate a substantial rise in cancer cases worldwide. For instance, projections suggest in 2022, approximately 20 million new cancer cases were reported globally, resulting in nearly 10 million deaths. Demographic projections suggest that the annual incidence of cancer will rise to 35 million by 2050, representing a 77% increase from 2022 figures. This surge is particularly pronounced in low- and middle-income countries, where healthcare infrastructure may struggle to accommodate the growing burden.

Key Market Challenges

Limited Awareness and Education

One of the primary challenges is the lack of awareness among patients undergoing radiation therapy. For many individuals diagnosed with cancer, the focus understandably shifts to the cancer itself and its treatment. Patients may not be fully informed about the potential side effects of radiation therapy, which can include skin irritation, fatigue, gastrointestinal issues, and damage to healthy tissues. Consequently, they may not actively seek information about radiation toxicity treatment options that could mitigate these adverse effects.

This lack of awareness can lead to suboptimal patient experiences, as individuals may not be proactive in discussing radiation toxicity concerns with their healthcare providers. As a result, they may endure unnecessary discomfort and a reduced quality of life during their treatment journey.

Key Market Trends

Radioprotective Agents and Supportive Care

Radioprotective agents and supportive care have emerged as powerful drivers boosting the Global Radiation Toxicity Treatment Market. These components of radiation toxicity management are gaining increasing attention and significance in the field of cancer care.

Radioprotective agents are pharmaceuticals and treatments developed to shield healthy tissues from the damaging effects of radiation therapy while simultaneously enhancing the tumor's sensitivity to radiation. These agents are designed to minimize radiation-induced toxicities, making radiation therapy safer and more tolerable for patients. The development of radioprotective drugs represents a major breakthrough, as it allows oncologists to optimize radiation treatment protocols without compromising their efficacy. As a result, patients can receive higher doses of radiation to target cancer cells more effectively while experiencing fewer side effects, driving the demand for such agents and boosting the radiation toxicity treatment market.

Key Market Players

• Amgen Inc.
• Jubilant Pharma Limited
• Tanner Pharma Group
• Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
• Recipharm AB
• Mission Pharmacal Company
• Partner Therapeutics, Inc.
• Novartis AG
• Viatris Inc.
• Coherus Biosciences Inc

Report Scope:

In this report, the Global Radiation Toxicity Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Radiation Toxicity Treatment Market, By Product:

• Colony Stimulating Factors
• Potassium Iodide
• Prussian Blue Diethylenetriamine Pentaacetic Acid
• Others

Radiation Toxicity Treatment Market, By Indication:

• Acute Radiation Syndrome
• Chronic Radiation Syndrome

Radiation Toxicity Treatment Market, By End-user:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Radiation Toxicity Treatment Market, By Radiation Type:

• Ionizing Radiation
• Non-ionizing Radiation

Radiation Toxicity Treatment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Radiation Toxicity Treatment Market.

Available Customizations:

Global Radiation Toxicity Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Radiation Toxicity Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Colony Stimulating Factors, Potassium Iodide, Prussian Blue Diethylenetriamine Pentaacetic Acid, Others)
  • 5.2.2. By Indication (Acute Radiation Syndrome, Chronic Radiation Syndrome)
  • 5.2.3. By Radiation Type (Ionizing Radiation, Non-ionizing Radiation)
  • 5.2.4. By End-user (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Radiation Toxicity Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Indication
  • 6.2.3. By Radiation Type
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Radiation Toxicity Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By Radiation Type
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Radiation Toxicity Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By Radiation Type
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Radiation Toxicity Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By Radiation Type
      • 6.3.3.2.4. By End User

7. Europe Radiation Toxicity Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Indication
  • 7.2.3. By Radiation Type
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Radiation Toxicity Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By Radiation Type
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Radiation Toxicity Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By Radiation Type
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Radiation Toxicity Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By Radiation Type
      • 7.3.3.2.4. By End User
  • 7.3.4. France Radiation Toxicity Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By Radiation Type
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Radiation Toxicity Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By Radiation Type
      • 7.3.5.2.4. By End User

8. Asia-Pacific Radiation Toxicity Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Indication
  • 8.2.3. By Radiation Type
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Radiation Toxicity Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By Radiation Type
      • 8.3.1.2.4. By End User
  • 8.3.2. India Radiation Toxicity Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By Radiation Type
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Radiation Toxicity Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By Radiation Type
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Radiation Toxicity Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By Radiation Type
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Radiation Toxicity Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By Radiation Type
      • 8.3.5.2.4. By End User

9. South America Radiation Toxicity Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Indication
  • 9.2.3. By Radiation Type
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Radiation Toxicity Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By Radiation Type
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Radiation Toxicity Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By Radiation Type
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Radiation Toxicity Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By Radiation Type
      • 9.3.3.2.4. By End User

10. Middle East and Africa Radiation Toxicity Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Indication
  • 10.2.3. By Radiation Type
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Radiation Toxicity Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By Radiation Type
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Radiation Toxicity Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By Radiation Type
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Radiation Toxicity Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By Radiation Type
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Radiation Toxicity Treatment Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Amgen Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Jubilant Pharma Limited
• 14.3. Tanner Pharma Group
• 14.4. Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
• 14.5. Recipharm AB
• 14.6. Mission Pharmacal Company
• 14.7. Partner Therapeutics, Inc.
• 14.8. Novartis AG
• 14.9. Viatris Inc.
• 14.10.Coherus Biosciences Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

관련자료